HomeNewsBusinessMarketsJefferies bullish on ICICI Lombard's 'Elevate' product, stock nears 52-week high

Jefferies bullish on ICICI Lombard's 'Elevate' product, stock nears 52-week high

Jefferies highlighted that the unlimited sum insured and customisation options in 'Elevate' could significantly bolster ICICI Lombard's market share in retail health

July 02, 2024 / 09:49 IST
Story continues below Advertisement
ICICI Lombard
So far this year, shares of this private insurance player has surged over 27 percent, beating benchmark Nifty 50 index that rose over 10 percent during the same period

Shares of ICICI Lombard rose over 1 percent to Rs 1,831 per share on July 2, nearing its 52-week high of Rs 1,832 per share following a 'buy' recommendation from Jefferies, which set a target price of Rs 2,090. Analysts view the company's new health insurance product 'Elevate' as a potential game-changer in the underpenetrated retail health market.

So far this year, shares of this private insurance player has surged over 27 percent, beating benchmark Nifty 50 index that rose over 10 percent during the same period.

Story continues below Advertisement

Catch all the market action on our LIVE blog

ICICI Lombard's 'Elevate' introduces advanced features such as AI-driven coverage, 'Power Booster' add-ons, and reset benefits, enhancing personalised and continuous health insurance coverage.